Citi Pharma 1QFY27 profit rises 22% to Rs249m

News Image

MG News | November 02, 2026 at 10:01 AM GMT+05:00

November 02, 2026 (MLN): Consolidated profit for the period of Citi Pharma Limited (PSX: CPHL) rose 22.14% year-on-year to Rs248.79m for the quarter ended September 30, 2026, compared with Rs203.69m in the same period last year.

Basic and diluted earnings per share (EPS) increased 22.47% to Rs1.09 from Rs0.89 in the corresponding quarter last year.

The growth came from a 29.92% rise in gross profit and a 16.93% cut in financial charges. Higher marketing and distribution expenses, lower other income and a heavier tax charge partly offset the gains.

Net sales grew 4.28% to Rs3.51bn from Rs3.37bn. Cost of sales edged down 0.39% to Rs2.84bn from Rs2.85bn, which lifted gross profit 29.92% to Rs674.26m from Rs518.97m.

Administrative and general expenses increased 10.20% to Rs55.31m from Rs50.19m, while marketing and distribution expenses more than doubled, up 122.58% to Rs107.79m from Rs48.43m.

As a result, operating profit climbed 21.60% to Rs511.16m from Rs420.36m.

Financial charges fell 16.93% to Rs100.67m from Rs121.19m, providing relief. Other income declined 45.14% to Rs15.78m from Rs28.77m, while other expenses rose 28.96% to Rs33.08m from Rs25.65m.

Profit before income taxes and final taxes, equal to profit before income tax, grew 30.08% to Rs393.19m from Rs302.28m.

Income tax rose 46.47% to Rs144.40m from Rs98.59m, which absorbed part of the gains and left profit for the period at Rs248.79m.

CONSOLIDATED STATEMENT OF PROFIT OR LOSS FOR QUARTER ENDED SEPTEMBER 30, 2026 (Rupees)

Description

2026

2025

Change (%)

Sales - net

3,514,442,888

3,370,247,671

4.28%

Cost of sales

(2,840,180,400)

(2,851,274,049)

-0.39%

Gross profit

674,262,488

518,973,622

29.92%

Administrative and general expenses

(55,306,154)

(50,188,888)

10.20%

Marketing and distribution expenses

(107,794,108)

(48,429,697)

122.58%

Operating profit

511,162,226

420,355,037

21.60%

Financial charges

(100,672,701)

(121,191,504)

-16.93%

Other income

15,781,983

28,766,096

-45.14%

Other expenses

(33,079,408)

(25,651,370)

28.96%

Profit before income taxes and final taxes

393,192,100

302,278,259

30.08%

Profit before income tax

393,192,100

302,278,259

30.08%

Taxation - income tax

(144,399,616)

(98,587,386)

46.47%

Profit for the period

248,792,484

203,690,873

22.14%

Earnings per share - basic and diluted (Rupees)

1.09

0.89

22.47%

 

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 165,869.96
82.85M
-0.32%
-539.30
ALLSHR 100,241.76
169.68M
-0.46%
-466.02
KSE30 48,707.90
13.34M
-0.65%
-318.75
KMI30 236,695.39
18.90M
-0.54%
-1276.36
KMIALLSHR 64,655.41
114.98M
-0.57%
-368.57
BKTi 45,478.31
3.86M
-1.01%
-465.92
OGTi 33,394.26
0.80M
-0.76%
-254.32
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 78,470.00 79,040.00
76,820.00
1500.00
1.95%
BRENT CRUDE 109.75 112.41
109.60
-3.68
-3.24%
RICHARDS BAY COAL MONTHLY 134.00 0.00
0.00
0.75
0.56%
ROTTERDAM COAL MONTHLY 148.05 0.00
0.00
0.30
0.20%
USD RBD PALM OLEIN 1,182.50 1,182.50
1,182.50
0.00
0.00%
CRUDE OIL - WTI 100.48 102.75
100.42
-3.64
-3.50%
SUGAR #11 WORLD 19.37 0.00
0.00
0.01
0.05%

Chart of the Day


Latest News
November 02, 2026 at 10:47 AM GMT+05:00

Practical reforms to stabilize LPG prices and supply


November 02, 2026 at 10:29 AM GMT+05:00

Qatar condemns attack on LNG carrier Al Mayeda in Arabian Gulf


November 02, 2026 at 10:19 AM GMT+05:00

Liven Pharma cuts quarterly loss by 76% to Rs7m


November 02, 2026 at 10:01 AM GMT+05:00

Citi Pharma 1QFY27 profit rises 22% to Rs249m


November 02, 2026 at 09:59 AM GMT+05:00

Adal Fintech moves closer to PSX listing



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg